MJP Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364K | Buy |
5,271
+1,613
| +44% | +$111K | 0.05% | 158 |
|
|
2025
Q1 | $254K | Sell |
3,658
-1,387
| -27% | -$96.3K | 0.05% | 180 |
|
|
2024
Q4 | $434K | Sell |
5,045
-787
| -13% | -$67.7K | 0.08% | 129 |
|
|
2024
Q3 | $694K | Buy |
5,832
+969
| +20% | +$115K | 0.13% | 83 |
|
|
2024
Q2 | $694K | Buy |
4,863
+398
| +9% | +$56.8K | 0.14% | 80 |
|
|
2024
Q1 | $573K | Buy |
4,465
+583
| +15% | +$74.9K | 0.12% | 88 |
|
|
2023
Q4 | $402K | Buy |
3,882
+77
| +2% | +$7.97K | 0.11% | 92 |
|
|
2023
Q3 | $346K | Buy |
+3,805
| New | +$346K | 0.1% | 88 |
|